To investigate the connection between the BCR::ABL1 fusion clone and the JAK2-mutated clone, we analyzed the mutational burden of JAK2 at diagnosis of BCR::ABL1-negative MPN and at diagnosis of CML in 7 patients. Here, JAK2 is linked to myeloproliferative disorder.